Related Experiment Videos

Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial

Gerd Bodlaj1, Robert Pichler, Walter Brandstätter

  • 1Second Department of Medicine, General Hospital Linz, Linz, Austria. gerd.bodlaj@akh.linz.at

Annals of Medicine
|September 14, 2007
PubMed

Insights

Hyperthyroidism in Graves' disease (GD) increases arterial stiffness and NT-pro-B-type natriuretic peptide (NT-ProBNP) levels, indicating volume overload. Reduced subendocardial perfusion is linked to higher heart rates, potentially explaining increased cardiovascular events.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Physiology

Background:

  • Arterial stiffness is a key factor in cardiovascular events.
  • Hyperthyroidism is associated with elevated cardiovascular event rates.

Purpose of the Study:

  • To evaluate systemic arterial stiffness, volume homeostasis, and subendocardial perfusion markers in Graves' disease (GD) patients.
  • To examine the interrelationship of these markers during hyperthyroidism and euthyroidism.

Main Methods:

  • Applanation tonometry used to measure aortic augmentation index (AIx@75) for arterial stiffness and subendocardial viability ratio (SEVR) for perfusion.
  • Measurements compared between hyperthyroid and euthyroid GD patients and correlated with NT-pro-B-type natriuretic peptide (NT-ProBNP) levels.

Main Results:

  • AIx@75 and NT-ProBNP levels were significantly elevated in hyperthyroidism versus euthyroidism, showing a positive correlation.
  • SEVR was significantly reduced in hyperthyroidism, primarily due to increased heart rates (SEVR75).

Conclusions:

  • Hyperthyroidism in GD patients leads to increased arterial stiffness and NT-ProBNP, suggesting volume overload.
  • Decreased subendocardial perfusion in hyperthyroidism is mainly attributed to elevated heart rates.
  • These hemodynamic changes may contribute to the higher cardiovascular event rates observed in GD.
Abstract

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...